Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women.
Paoletti
Anna Maria
AM
Clinica Ginecologica Ostetrica e di Fisiopatologia della Riproduzione Umana del Dipartimento Chirurgico Materno-Infantile e di Scienze delle Immagini, Università degli Studi di Cagliari Via Ospedale 46, 09124 Cagliari, Italy.
Orrù
Marisa
M
Lello
Stefano
S
Floris
Stefano
S
Ranuzzi
Francesca
F
Etzi
Rossella
R
Zedda
Pierina
P
Guerriero
Stefano
S
Fratta
Stefania
S
Sorge
Roberto
R
Mallarini
Giorgio
G
Melis
Gian Benedetto
GB
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000596:Amino Acids / Q000652:urine; D000736:Androstenes / Q000008:administration & dosage / Q000009:adverse effects*; D015415:Biomarkers / Q000032:analysis*; D015992:Body Mass Index; D015519:Bone Density; D016723:Bone Remodeling / Q000187:drug effects*; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D003404:Creatinine / Q000652:urine; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015675:Osteocalcin / Q000097:blood; D011374:Progesterone / Q000097:blood; D012738:Sex Hormone-Binding Globulin / Q000032:analysis; D013739:Testosterone / Q000097:blood; D049629:Waist-Hip Ratio
D000596:Amino Acids; D000736:Androstenes; D015415:Biomarkers; D003276:Contraceptives, Oral; D012738:Sex Hormone-Binding Globulin; D015675:Osteocalcin; D013739:Testosterone; D004997:Ethinyl Estradiol; D011374:Progesterone; C015484:pyridinoline; C036020:deoxypyridinoline; D003404:Creatinine; D000469:Alkaline Phosphatase; C035144:drospirenone